N/A
N=583
Evaluation of Intensive Management Patient Aligned Care Team
Primary Health Care · Health Care Costs
Bottom Line
View on ClinicalTrials.gov: NCT02932228 ↗Enrolled (actual)
583
Serious AEs
0.0%
Results posted
May 2019
Primary outcome: Primary: VA Health Care Costs — 6139; 5821; 4850; 4618 US Dollars
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- ImPACT (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- VA Office of Research and Development
- Primary completion
- Jun 2014
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY VA Health Care Costs |
6139; 5821; 4850; 4618 | — |
| SECONDARY Hospitalization |
1.3; 1.3; 0.7; 0.7 | — |
| SECONDARY Emergency Department Utilization |
3.4; 3.3; 2.1; 2.1 | — |
| SECONDARY Outpatient Utilization |
10.9; 10.6; 21.8; 7.4 | — |
Summary
This evaluation will examine the feasibility, implementation, and effectiveness of a quality improvement intervention-Intensive Management Patient Aligned Care Team (ImPACT)-for high-risk patients.
Eligibility Criteria
Inclusion Criteria
- Patient receives care from one of 14 primary care providers (MDs, NPs) who have at least three half-days of clinic per week
- Total VA healthcare costs in the top 5% for VA Palo Alto facility during the 9-month eligibility phase (10/1/11-6/30/12) AND/OR
- Risk for one-year hospitalization in November 2012 in the top 5% (using the VA's Care Assessment Need risk-prediction algorithm)
Exclusion Criteria
- Enrollment in VA's mental health intensive case management program, home-based primary care, or palliative care programs
- Recipient of inpatient care for over half of the 9-month eligibility phase (10/1/11-6/30/12).
- Total VA healthcare costs in the lowest cost decile in the 9-month eligibility phase (10/1/11-6/30/12)
- Risk for one-year hospitalization in November 2012 in the lowest risk quartile (using the VA's Care Assessment Need risk-prediction algorithm).
Data sourced from ClinicalTrials.gov (NCT02932228). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.